BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29496470)

  • 1. Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.
    Kashan M; Ghanaat M; Hötker AM; Duzgol C; Sanchez A; DiNatale RG; Blum KA; Becerra MF; Manley BJ; Casuscelli J; Chiok M; Coleman JA; Russo P; Tickoo SK; Akin O; Hakimi AA
    J Urol; 2018 Aug; 200(2):275-282. PubMed ID: 29496470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review.
    Schoots IG; Zaccai K; Hunink MG; Verhagen PCMS
    J Urol; 2017 Jul; 198(1):12-21. PubMed ID: 28286071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bosniak category IIF and III cystic renal lesions: outcomes and associations.
    Smith AD; Remer EM; Cox KL; Lieber ML; Allen BC; Shah SN; Herts BR
    Radiology; 2012 Jan; 262(1):152-60. PubMed ID: 22106359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological characteristics and radiographic correlates of complex renal cysts.
    Reese AC; Johnson PT; Gorin MA; Pierorazio PM; Allaf ME; Fishman EK; Netto GJ; Pavlovich CP
    Urol Oncol; 2014 Oct; 32(7):1010-6. PubMed ID: 25022857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial.
    Narayan V; Puligandla M; Haas NB; Subramanian P; DiPaola RS; Uzzo R
    J Urol; 2019 Jan; 201(1):62-68. PubMed ID: 30130544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Renal Masses: Old and New Paradigms.
    Alrumayyan M; Raveendran L; Lawson KA; Finelli A
    Urol Clin North Am; 2023 May; 50(2):227-238. PubMed ID: 36948669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma.
    Procházková K; Mírka H; Trávníček I; Pitra T; Kolár J; Roušarová M; Hošek P; Bajcurová K; Ferda J; Staehler M; Brookman May SD; Hes O; Hora M
    Urol Int; 2018; 101(4):409-416. PubMed ID: 30199877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computed tomography.
    You D; Shim M; Jeong IG; Song C; Kim JK; Ro JY; Hong JH; Ahn H; Kim CS
    BJU Int; 2011 Nov; 108(9):1444-9. PubMed ID: 21722289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.
    Honda Y; Goto K; Nakamura Y; Terada H; Sentani K; Yasui W; Sekino Y; Hayashi T; Teishima J; Matsubara A; Fuji T; Kaichi Y; Higaki T; Baba Y; Iida M; Awai K
    Abdom Radiol (NY); 2017 Jul; 42(7):1850-1856. PubMed ID: 28534069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can a Modified Bosniak Classification System Risk Stratify Pediatric Cystic Renal Masses?
    Saltzman AF; Carrasco A; Colvin AN; Meyers ML; Cost NG
    J Urol; 2018 Aug; 200(2):434-439. PubMed ID: 29572157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Partial elective nephrectomy].
    Zungri E; Martínez L; Leal D; Lorenzo L
    Actas Urol Esp; 2012 Mar; 36(3):160-4. PubMed ID: 21955560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic outcomes of cystic renal cell carcinoma.
    Donin NM; Mohan S; Pham H; Chandarana H; Doshi A; Deng FM; Stifelman MD; Taneja SS; Huang WC
    Clin Genitourin Cancer; 2015 Feb; 13(1):67-70. PubMed ID: 25088469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses.
    Lee RA; Uzzo RG; Anaokar J; Thomas A; Wei S; Ristau BT; McIntosh A; Lee M; Chen DYT; Greenberg RE; Viterbo R; Smaldone MC; Correa A; Schober J; Ginsburg K; Bukavina L; Magee D; Uzzo N; Parkansky P; Ruth K; Kutikov A
    J Urol; 2023 Apr; 209(4):686-693. PubMed ID: 36630588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy Rate, Histologic Grade, and Progression of Bosniak Category III and IV Complex Renal Cystic Lesions.
    Mousessian PN; Yamauchi FI; Mussi TC; Baroni RH
    AJR Am J Roentgenol; 2017 Dec; 209(6):1285-1290. PubMed ID: 28981360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study).
    Nouhaud FX; Bernhard JC; Bigot P; Khene ZE; Audenet F; Lang H; Bergerat S; Fraisse G; Grenier N; Cornelis F; Nedelcu C; Béjar S; Fromont-Hankard G; Allory Y; Lindner V; Verkarre V; Daniel L; Yacoub M; Correas JM; Méjean A; Rioux-Leclercq N; Bensalah K
    World J Urol; 2018 Oct; 36(10):1643-1649. PubMed ID: 29730837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression, interobserver agreement, and malignancy rate in complex renal cysts ( ≥ Bosniak category IIF).
    El-Mokadem I; Budak M; Pillai S; Lang S; Doull R; Goodman C; Nabi G
    Urol Oncol; 2014 Jan; 32(1):24.e21-7. PubMed ID: 23395236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosniak Classification and other Variables in the Prediction of Renal Cystic Masses.
    Keseroglu B; Ozgur BC; Tastemur S; Irkilata L; Doluoglu OG; Yuceturk CN
    J Coll Physicians Surg Pak; 2019 May; 29(5):456-458. PubMed ID: 31036118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence of malignant transformation of renal cysts of category 1, 2, and 2F by the BOSNIAK classification into multilocular cystic renal cell carcinoma].
    Darenkov SP; Proskokov AA; Agabekian AA; Trofimov IA
    Urologiia; 2018 Jul; (3):111-115. PubMed ID: 30035429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.
    Lee Z; Jegede OA; Haas NB; Pins MR; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Flaherty KT; Dutcher JP; DiPaola RS; Uzzo RG
    J Urol; 2020 Apr; 203(4):684-689. PubMed ID: 31596672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Bosniak classification in malignant tumor diagnosis: A single institution experience.
    Oh TH; Seo IY
    Investig Clin Urol; 2016 Mar; 57(2):100-5; discussion 105. PubMed ID: 26981591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.